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A B S T R A C T
Background: Despite the frequent use of spectral analysis of intravascular ultrasound radiofrequency
data (VH1 IVUS) in clinical studies, the assessment for reproducibility using this with high frequency
IVUS remains unexplored.
Purpose: The aim of this study was to examine the reproducibility of VH IVUS using 45-MHz rotational
IVUS in ex vivo human coronary arteries.
Methods: Data were collected using 45-MHz VH IVUS (Revolution1, Volcano Corporation, San Diego, CA,
USA) via a series of pullbacks from eight human coronary artery specimens. Imaging data were analyzed
by two independent observers. Intraobserver and interobserver reproducibility were assessed using ﬁve
pullbacks from ﬁve vessels. The intercatheter reproducibility was assessed using three different
catheters in each of the ﬁve vessels. The intracatheter reproducibility was assessed between the two
sequential pullbacks from each of the 15 catheters used in the intercatheter assessment.
Results: Geometrical measurements consistently showed low variability (relative difference <10%) and
excellent intraclass correlation coefﬁcients (ICCs), ranging from 0.88 to 1.00. With respect to the
compositional measurements, the relative differences were predominantly higher than those of
geometrical measurements. In particular, ﬁbrous-fatty area showed a higher relative difference (17.5% in
intercatheter assessment) compared to ﬁbrous, necrotic core, and dense calcium areas (6.5%, 8.4%, and
6.4%, respectively). However, each compositional measurement also showed acceptable reproducibility
(ICCs ranging from 0.82 to 1.00).
Conclusions: The 45-MHz rotational VH IVUS technology had acceptable reproducibility with respect to
geometrical and compositional assessments in ex vivo human coronary arteries. These data are crucial
when designing future longitudinal studies addressing geometrical measurements and plaque
characterization by 45-MHz VH IVUS.
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Intravascular ultrasound (IVUS) facilitates the assessment of
extent, distribution, severity, and morphology in human
atherosclerotic coronary arteries [1–3]. In the ﬁeld of interven-
tional cardiology, IVUS has been used not only for therapeutic
decision making [4,5], but also for clinical research evaluating
serial changes in atherosclerotic coronary plaque size and
composition [6–10]. The spectral analysis of IVUS radiofre-
quency data (VH1 IVUS) facilitates plaque characterization. This
VH IVUS technology (Volcano Corporation, San Diego, CA, USA)
classiﬁes plaque components as ﬁbrous, ﬁbrous-fatty, necrotic
core, or dense calcium [11,12]. The predictive accuracy of the
20-MHz VH IVUS technology was previously examined by direct
comparison with pathohistology of ex vivo (97%) and in vivo
(95%) human coronary arteries [12,13]. These studies illustrated
the clinical signiﬁcance of VH IVUS images to assess the
distribution of the tissue components within the plaque [14].
Indeed, distributions of these components might reﬂect the
clinical characteristics of patients [15] and were also associated
with cardiovascular risk score [16]. A previous clinical trial
demonstrated that the presence of a thin-cap ﬁbroatheroma
detected by VH IVUS was an independent predictor of future
cardiac events [17]. It should also be noted that, in the IBIS-2
study, an Lp-PLA2 inhibitor darapladib (GlaxoSmithKline,
Philadelphia, PA, USA) was studied with regard to its capabilities
to modify plaque components. One of the key ﬁndings was that
Lp-PLA2 inhibition with darapladib interferes with necrotic core
expansion as assessed by VH IVUS [18]. This study highlighted
the potential of VH IVUS to detect changes in plaque that are
related to the mechanism of action of the investigational drugs.
Since the fate of coronary plaques is related to their histological
composition [19], valid plaque characterization could provide
clinically relevant information and become a therapeutic target
for future studies regarding pharmacological intervention [7–
9,18] and bioresorbable scaffold implantation [20,21].
The ﬁrst commercially available VH IVUS system was developed
with 20-MHz solid-state array IVUS. A new-generation 45-MHz
rotational VH IVUS has been developed and produces better
resolution images that might improve plaque characterization.
However, there have been no published data in terms of
reproducibility that is crucial for longitudinal studies. Therefore,
the aim of this study was to assess the reproducibility of
geometrical and compositional measurements using 45-MHz
rotational VH IVUS in ex vivo human coronary arteries.
Methods
Samples and imaging procedure
A total of nine harvested specimens of human coronary
arteries were used for this study. The mean age of the donors was
61.3 years, and all coronary artery specimens showed severe
atherosclerotic plaque. The specimens were pinned on a custom-
made room-temperature-vulcanizing silicone elastomer using
needles in a dissecting tray ﬁlled with saline during imaging.
The elastomer has acoustic impedance comparable to water in
order to minimize ultrasonic artifacts within the IVUS image. A
3.2-French, 45-MHz rotational IVUS catheter (Revolution1,
Volcano Corporation) was inserted from the ostium to the distal
end of the specimen. IVUS data were acquired with a pullback
speed of 0.5 mm/s. An electrocardiogram simulator (430B ECG
simulator, Medi Cal Instruments, Inc., Lewis Center, OH, USA) was
used to trigger the VH IVUS data acquisition at a frequency of 60
beats per minute.45-MHz VH IVUS data analysis
The IVUS data were recorded with a commercially available
IVUS console that was enabled for 45-MHz ultrasound backscatter
data acquisition (s5 Imaging System, Volcano Corporation). In each
pullback, the region of interest (ROI) was deﬁned using distal and
proximal side branches. The same side branches were used as
anatomical landmarks for each pullback data within a given vessel.
Contour detection of vessel lumen and media–adventitia interface
was independently performed by two experienced IVUS analysts.
QIvus Version 2.1 software (Medis, Leiden, The Netherlands) was
used for the off-line contour detection, and the virtual histology
(VH) images were processed with the contours using the VH OEM
Version 2.0.2 software (Volcano Corporation) that was modiﬁed
speciﬁcally to assess tissue characterization in ex vivo data in the
absence of blood attenuation.
Reproducibility assessment
In this study, we assessed the intraobserver, interobserver,
intracatheter, and intercatheter reproducibility. Among the nine
vessels (i.e., coronary artery specimens); one vessel was excluded
from the current analysis because of poor specimen quality due to
severe damage. For the assessment of intraobserver reproducibili-
ty, ﬁve pullbacks from ﬁve vessels were randomly selected and
analyzed twice at an interval of 2 weeks by the same observer
(i.e., agreement between 1st and 2nd analyses). For the assessment
of interobserver reproducibility, the same ﬁve pullbacks as used for
the intraobserver assessment were analyzed by two independent
analysts (i.e., agreement between observer 1 and observer 2). In
addition, ﬁve vessels were evaluated by three catheters each with
two sequential pullbacks per catheter, leading to the capability of
multiple assessments: intracatheter reproducibility comparing
two sequential pullbacks with 15 catheters (i.e., agreement
between 1st and 2nd pullbacks), and intercatheter reproducibility
comparing the ﬁrst pullback of catheter 1, catheter 2, and catheter
3 in each vessel (i.e., agreement among three catheters).
We applied the frame-level analysis for the assessment of
intraobserver and interobserver reproducibility because all the
same frames (i.e., crosssections) should be analyzed, while the
segment-level analysis was applied for the assessment of
intracatheter and intercatheter reproducibility because the ana-
lyzed crosssections could be different between the pullbacks even
after matching the segments with the landmark side branches.
Each component of geometrical and compositional measurements
was compared under the aforementioned conditions.
Statistical analysis
Descriptive variables are presented as means  standard
deviations (SDs). The reproducibility with corresponding 95%
conﬁdence intervals (CIs) was determined using intraclass correlation
coefﬁcients (ICCs). Bland–Altman plots were generated to estimate
the limit of agreement (LOA) deﬁned as the mean difference of
measurements between the two conditions  2 SD [22]. Statistical
analysis was performed with PASW 18 software (SPSS Inc., Chicago,
IL, USA).
Results
Intraobserver agreement
The mean length of ROI was 20.5  4.1 mm for the ﬁve pullbacks.
Geometrical and compositional data of the matched frames are
shown in Table 1. The relative intraobserver differences in
geometrical measurements were negligible. Of note, the relative
Table 1
Geometrical and compositional measurements of the same frames with two subsequent analyses (intraobserver agreement).
Variables 1st analysis 2nd analysis Difference LOAa ICC (95% CI)
Absolute Relative (%) Lower Upper
Geometrical data
Lumen CSA (mm2) 6.77  1.94 6.74  1.95 0.03  0.51 0.4 1.05 1.00 0.98 (0.98–0.99)
Lumen minimum diameter (mm) 2.48  0.46 2.47  0.46 0.02  0.16 0.7 0.33 0.30 0.97 (0.96–0.98)
Lumen maximum diameter (mm) 3.39  0.56 3.38  0.55 0.01  0.15 0.3 0.31 0.28 0.98 (0.98–0.99)
Lumen mean diameter (mm) 2.88  0.44 2.87  0.44 0.01  0.12 0.2 0.24 0.22 0.98 (0.98–0.99)
Vessel CSA (mm2) 17.49  3.99 17.79  3.99 0.31  0.60 1.7 0.90 1.51 0.99 (0.99–1.00)
Vessel minimum diameter (mm) 4.45  0.57 4.48  0.57 0.02  0.11 0.5 0.19 0.23 0.99 (0.99–0.99)
Vessel maximum diameter (mm) 4.93  0.55 4.99  0.57 0.06  0.13 1.3 0.20 0.33 0.98 (0.98–0.99)
Vessel mean diameter (mm) 4.68  0.55 4.72  0.55 0.04  0.09 0.9 0.14 0.22 0.99 (0.99–0.99)
Plaque area (mm2) 10.72  3.42 11.05  3.46 0.33  0.76 3.1 1.19 1.85 0.99 (0.98–0.99)
Plaque burden (%) 60.81  9.76 61.59  9.72 0.78  3.50 1.3 6.22 7.78 0.97 (0.95–0.97)
Compositional data
Fibrous area (mm2) 2.81  1.57 2.88  1.56 0.07  0.24 2.3 0.41 0.54 0.99 (0.99–1.00)
Fibrous tissue (%) 38.75  15.87 38.50  15.87 0.25  2.92 0.6 6.09 5.59 0.99 (0.99–0.99)
Fibrous-fatty area (mm2) 2.87  2.22 3.03  2.29 0.16  0.48 5.5 0.80 1.11 0.99 (0.98–0.99)
Fibrous-fatty tissue (%) 36.09  17.36 36.60  17.28 0.51  4.48 1.4 8.45 9.48 0.98 (0.98–0.99)
Necrotic core area (mm2) 1.15  0.66 1.21  0.68 0.06  0.15 5.1 0.24 0.35 0.99 (0.98–0.99)
Necrotic core tissue (%) 17.12  8.95 17.08  8.54 0.04  2.25 0.2 4.53 4.45 0.98 (0.98–0.99)
Dense calcium area (mm2) 0.52  0.48 0.54  0.49 0.02  0.08 3.2 0.14 0.17 0.99 (0.99–1.00)
Dense calcium tissue (%) 8.04  7.05 7.82  6.76 0.22  1.57 2.8 3.37 2.92 0.99 (0.98–0.99)
N = 5 pullbacks with 210 frames.
CSA, cross-sectional area; LOA, limit of agreement; ICC, intraclass correlation coefﬁcient.
a LOA was deﬁned as mean  2 SD of absolute difference by Bland–Altman method.
T. Muramatsu et al. / Journal of Cardiology 65 (2015) 134–142136differences in plaque area and plaque burden were 3.1% and 1.3%,
respectively. Although compositional measurements showed slightly
greater relative differences than geometrical measurements, the
relative differences were consistently less than 10%, with the greatestFig. 1. Bland–Altman plots depicting the intraobserrelative difference of 5.5% for ﬁbrous-fatty area. The ICCs showed
excellent reproducibility and Bland–Altman plots showed narrow
LOAs in both geometrical (Fig. 1) and compositional (Fig. 2)
measurements. The LOAs for lumen, vessel, and plaque areas werever agreement for geometrical measurements.
Fig. 2. Bland–Altman plots depicting the intraobserver agreement for compositional measurements.
T. Muramatsu et al. / Journal of Cardiology 65 (2015) 134–142 1371.00, 1.05 mm2; 1.51, 0.90 mm2; and 1.85, 1.19 mm2, respec-
tively. The LOAs for the area measurements of ﬁbrous, ﬁbrous-fatty,
necrotic core, and dense calcium were 0.54, 0.41 mm2; 1.11,
0.80 mm2; 0.35, 0.24 mm2; and 0.17, 0.14 mm2, respectively.Table 2
Geometrical and compositional measurements of the same frames by two observers (i
Variables Observer 1 Observer 2 D
A
Geometrical data
Lumen CSA (mm2) 6.77  1.94 7.01  1.90 0
Lumen minimum diameter (mm) 2.48  0.46 2.55  0.42 0
Lumen maximum diameter (mm) 3.39  0.56 3.40  0.54 0
Lumen mean diameter (mm) 2.88  0.44 2.94  0.41 0
Vessel CSA (mm2) 17.49  3.99 17.51  4.04 0
Vessel minimum diameter (mm) 4.45  0.57 4.43  0.56 0
Vessel maximum diameter (mm) 4.93  0.55 4.96  0.57 0
Vessel mean diameter (mm) 4.68  0.55 4.69  0.55 0
Plaque area (mm2) 10.72  3.42 10.51  3.56 0
Plaque burden (%) 60.81  9.76 59.14  10.06 1
Compositional data
Fibrous area (mm2) 2.81  1.57 2.67  1.52 0
Fibrous tissue (%) 38.75  15.87 38.43  16.19 0
Fibrous-fatty area (mm2) 2.87  2.22 2.92  2.29 0
Fibrous-fatty tissue (%) 36.09  17.36 37.26  18.36 1
Necrotic core area (mm2) 1.15  0.66 1.08  0.66 0
Necrotic core tissue (%) 17.12  8.95 16.41  8.66 0
Dense calcium area (mm2) 0.52  0.48 0.51  0.47 0
Dense calcium tissue (%) 8.04  7.05 7.91  6.79 0
N = 5 pullbacks with 210 frames in each observer.
CSA, cross-sectional area; LOA, limit of agreement; ICC, intraclass correlation coefﬁci
a LOA was deﬁned as mean  2 SD of absolute difference by Bland–Altman method.Interobserver agreement
Geometrical and compositional data of the matched frames
are shown in Table 2. The relative interobserver differencesnterobserver agreement).
ifference LOAa ICC (95% CI)
bsolute Relative (%) Lower Upper
.24  0.54 3.6 0.84 1.32 0.98 (0.97–0.98)
.07  0.16 2.7 0.25 0.38 0.96 (0.95–0.97)
.01  0.18 0.2 0.35 0.37 0.97 (0.96–0.98)
.06  0.13 2.1 0.19 0.31 0.97 (0.96–0.98)
.03  1.05 0.2 2.08 2.14 0.98 (0.98–0.99)
.02  0.18 0.5 0.38 0.34 0.97 (0.97–0.98)
.03  0.19 0.6 0.35 0.41 0.97 (0.96–0.98)
.00  0.15 0.0 0.29 0.30 0.98 (0.98–0.99)
.21  1.19 2.0 2.60 2.17 0.97 (0.96–0.98)
.67  4.35 2.8 10.37 7.02 0.94 (0.92–0.96)
.14  0.34 5.0 0.83 0.55 0.99 (0.98–0.99)
.33  3.31 0.8 6.94 6.29 0.99 (0.99–0.99)
.05  0.76 1.7 1.47 1.56 0.97 (0.96–0.98)
.16  5.35 3.2 9.53 11.86 0.98 (0.97–0.98)
.07  0.19 6.1 0.46 0.32 0.98 (0.97–0.98)
.71  2.56 4.1 5.84 4.42 0.98 (0.97–0.98)
.02  0.10 3.2 0.21 0.18 0.99 (0.99–0.99)
.13  2.10 1.6 4.34 4.08 0.98 (0.97–0.98)
ent.
Fig. 3. Bland–Altman plots depicting the interobserver agreement for geometrical measurements.
T. Muramatsu et al. / Journal of Cardiology 65 (2015) 134–142138in geometrical measurements were also negligible and those of
plaque area and plaque burden were 2.0% and 2.8%, respectively.
With respect to compositional measurements, the relative
differences were consistently less than 10% and ICCs showed
excellent reproducibility. Bland–Altman plots showed narrow
LOAs in both geometrical (Fig. 3) and compositional (Fig. 4)
measurements. The LOAs for lumen, vessel, and plaque areas
were 1.32, 0.84 mm2; 2.14, 2.08 mm2; and 2.17, 2.60 mm2,
respectively. The LOAs for the area measurements of ﬁbrous,
ﬁbrous-fatty, necrotic core, and dense calcium were 0.55,
0.83 mm2; 1.56, 1.47 mm2; 0.32, 0.46 mm2; and 0.18,
0.21 mm2, respectively.
Intracatheter agreement
Geometrical and compositional data of the matched ROI
are shown in Table 3. A total of 15 catheters were used
for the present data analysis. The relative intracatheter
differences were less than 5% in both geometrical and
compositional measurements. ICCs predominantly showed
excellent reproducibility except for the proportional measure-
ment of ﬁbrous-fatty plaque, although the coefﬁcient was 0.84.
The LOAs for lumen, vessel, and plaque areas were 0.44,
0.50 mm2; 1.05, 0.77 mm2; and 1.23, 0.89 mm2, respec-
tively. The LOAs for the area measurements of ﬁbrous, ﬁbrous-
fatty, necrotic core, and dense calcium were 0.30, 0.21 mm2;
1.10, 0.88 mm2; 0.22, 0.20 mm2; and 0.16, 0.18 mm2,
respectively.Intercatheter agreement
Geometrical and compositional data of the matched ROI are
shown in Table 4. With respect to geometrical measurements, the
mean relative differences were less than 10% and ICCs showed
good agreement, ranging from 0.88 to 1.00. Although ﬁbrous-fatty
area showed greater variability than the other compositional
measurements (average relative difference, 17.5%), ICCs showed
good reproducibility, ranging from 0.82 to 1.00. Considering the
average plaque area (10.9 mm2), however, the average of absolute
difference in ﬁbrous-fatty area was numerically small (0.46 mm2).
Discussion
Gray-scale IVUS has been employed as a gold standard of
geometrical assessment of coronary plaque [23]. VH IVUS was
introduced as a complementary technology that provides an
accurate compositional assessment of plaque [11–13]. Several
previous studies employed the 20-MHz VH IVUS technology to
evaluate the temporal changes in plaque composition after
pharmacological intervention [7–9,18] or bioresorbable scaffold
implantation [20,24]. The VH IVUS algorithm was recently
developed for a 45-MHz rotational IVUS catheter. The higher
frequency of the 45-MHz rotational catheter provides the potential
for improved VH IVUS with the cost of increased attenuation and
reduced imaging ﬁeld-of-view in comparison with the 20-MHz
solid-state array IVUS. Understanding the reproducibility of the
Fig. 4. Bland–Altman plots depicting the interobserver agreement for compositional measurements.
T. Muramatsu et al. / Journal of Cardiology 65 (2015) 134–142 13945-MHz VH IVUS algorithm is critical to create a foundation on
which to design future longitudinal studies.
In this study, a narrow range of agreement was demonstrated
by the Bland–Altman plots. The relative differences of geometricalTable 3
Geometrical and compositional measurements of the matched ROI with two subseque
Variables 1st pullback 2nd pullback Di
Ab
Geometrical data
Lumen CSA (mm2) 6.74  0.86 6.70  0.71 0
Lumen minimum diameter (mm) 2.50  0.20 2.51  0.17 0.0
Lumen maximum diameter (mm) 3.32  0.19 3.31  0.15 0
Lumen mean diameter (mm) 2.88  0.19 2.88  0.16 0.0
Vessel CSA (mm2) 17.55  3.20 17.69  2.98 0
Vessel minimum diameter (mm) 4.42  0.46 4.44  0.44 0
Vessel maximum diameter (mm) 4.98  0.41 5.00  0.37 0
Vessel mean diameter (mm) 4.69  0.43 4.71  0.41 0
Plaque area (mm2) 10.81  2.98 10.98  2.72 0
Plaque burden (%) 60.92  6.01 61.65  5.39 0
Compositional data
Fibrous area (mm2) 2.38  0.95 2.43  0.93 0
Fibrous tissue (%) 33.48  7.98 33.62  8.57 0
Fibrous-fatty area (mm2) 2.62  1.14 2.73  1.09 0
Fibrous-fatty tissue (%) 33.95  4.38 34.44  5.49 0
Necrotic core area (mm2) 1.56  0.62 1.57  0.56 0
Necrotic core tissue (%) 20.68  3.02 20.49  2.95 0
Dense calcium area (mm2) 0.88  0.44 0.87  0.43 0
Dense calcium tissue (%) 11.73  5.02 11.45  5.35 0
N = 15 catheters sequentially pulled back in ﬁve vessels.
CSA, cross-sectional area; LOA, limit of agreement; ICC, intraclass correlation coefﬁci
a LOA was deﬁned as mean  2 SD of absolute difference by Bland–Altman method.measurements were predominantly less than 3% and ICCs
were high. It should be noted that plaque burden, which is one
of the most commonly used primary endpoints in IVUS studies
evaluating plaque progression/regression, showed excellentnt pullbacks (intracatheter agreement).
fference LOAa ICC (95% CI)
solute Relative (%) Lower Upper
.03  0.23 0.47 0.50 0.44 0.98 (0.94–0.99)
04  0.071 0.14 0.14 0.15 0.96 (0.90–0.99)
.01  0.05 0.24 0.10 0.08 0.98 (0.95–0.99)
04  0.050 0.13 0.10 0.10 0.98 (0.95–0.99)
.14  0.46 0.80 0.77 1.05 0.99 (0.98–1.00)
.02  0.05 0.56 0.08 0.13 1.00 (0.99–1.00)
.02  0.08 0.38 0.14 0.18 0.99 (0.97–1.00)
.02  0.06 0.49 0.09 0.14 1.00 (0.99–1.00)
.17  0.53 1.59 0.89 1.23 0.99 (0.97–1.00)
.73  1.30 1.19 1.87 3.32 0.98 (0.95–0.99)
.04  0.13 1.86 0.21 0.30 1.00 (0.99–1.00)
.14  1.65 0.40 3.16 3.43 0.99 (0.97–1.00)
.11  0.49 4.25 0.88 1.10 0.95 (0.85–0.98)
.48  3.74 1.42 7.01 7.97 0.84 (0.54–0.95)
.01  0.11 0.65 0.20 0.22 0.99 (0.98–1.00)
.19  1.60 0.91 3.38 3.01 0.93 (0.79–0.98)
.01  0.09 0.86 0.18 0.16 0.99 (0.97–1.00)
.27  1.31 2.34 2.89 2.34 0.98 (0.96–1.00)
ent.
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T. Muramatsu et al. / Journal of Cardiology 65 (2015) 134–142140reproducibility in any settings of assessment (ICC ranging from
0.94 to 0.98).
Although compositional measurements generally resulted in
greater relative differences, indicating greater variability, than
those of geometrical measurements, the reproducibility was
generally acceptable (ICC ranged from 0.82 to 1.00). These results
are in line with the previous studies evaluating the reproducibility
of 20-MHz VH IVUS and 40-MHz iMAP catheter [25,26]. Another
key observation is that necrotic core measurements showed only
slight variability and excellent reproducibility. This result is of
great importance since necrotic core has been considered the most
clinically relevant plaque component in predicting adverse
cardiovascular events [17] and has the potential to be a key focus
of longitudinal studies [27].
In contrast, area (mm2) and proportional (%) estimates of
ﬁbrous-fatty plaque generally demonstrated greater variability
and lower reproducibility compared to the other plaque
components. A major limitation of radiofrequency (RF)-based
plaque characterization is the technical problem with respect to
acoustic shadowed area. In severely calciﬁed lesions, RF signals
are more likely to contain noise because of reﬂection by thick
layers of calciﬁcation. This phenomenon leads to potential biases
as follows: (1) an observer-related bias as the acoustic shadow
often makes vessel boundaries (i.e., media–adventitia interface)
invisible that potentially results in miscalculation of vessel area;
(2) a software-related bias as the signal processing algorithm
does not take the shadowed area into account and will
automatically assign the pixels in these regions to the other
components within their database based on the noise [28].
Indeed, our sample coronary arteries appeared to be more
severely diseased with higher compositions of necrotic core and
dense calcium compared to those in the previous reproducibility
studies of plaque characterization techniques [25,26]. An
example of intracatheter reproducibility assessment in severely
calciﬁed lesion is shown in Fig. 5. ROI was perfectly matched
between the two sequential pullbacks detecting the morphology
of calciﬁcation and a landmark side branch (yellow asterisk).
Generally these two pullbacks looked similar in terms of plaque
distributions in both segment-level analysis (area charts) and
frame-level analysis (lower images as shown in Frame 33). In the
matched frames with severe calciﬁcation, however, vessel
boundaries were invisible and resulted in an apparently different
contour detection of vessel area between the two pullbacks
(middle images as shown in Frame 22). Plaque behind the
calciﬁcation was generally characterized as ﬁbrous-fatty tissue,
and consequently plaque area and ﬁbrous-fatty area showed
the differences between the two pullbacks in this sampled
frame. Therefore, our result is not surprising since saline and
the shadowed regions behind dense calcium both will generally
be classiﬁed as ﬁbrous-fatty due to the higher attenuation of
45-MHz VH IVUS. Inclusion of saline area inside the lumen
or beyond the vessel when evaluating severely calciﬁed
regions will also result in a disproportionate increase in
ﬁbrous-fatty tissue as compared to the other plaque compo-
nents. A previous histological study demonstrated that 83% of
coronary lesions behind severely calciﬁed lesions had an
extensive necrotic tissue containing large numbers of cholester-
ol crystals and microcalciﬁcations [29]. Careful attention should
thus be required to interpret the plaque composition in severely
calciﬁed lesions.
The precise contour detection has an essential role in the
reproducibility of VH IVUS measurements for either 20-MHz or
45-MHz catheters. Despite the potential error of imaging analysis
as previously mentioned, ICCs showed excellent reproducibility
and relative differences of measurements were predominantly less
than the commonly accepted threshold (10%) in the present study.
Fig. 5. An example of intracatheter reproducibility assessment in a severely calciﬁed vessel. Sequential plotting of a matched region of interest (ROI) interrogated with two
pullbacks using the same catheter (intracatheter reproducibility assessment). The mean cross-sectional area (CSA) (y-axis) of each plaque component is color coded (necrotic
core, red; dense calcium, white; ﬁbrous, green; and ﬁbrous-fatty, greenish-yellow). This ﬁgure shows the impact of severe calciﬁcation on the assessments for geometrical
and compositional measurements.
T. Muramatsu et al. / Journal of Cardiology 65 (2015) 134–142 141Our results could provide important information in order to
perform more precise power calculations for future longitudinal
studies.
Study limitations
The present study was conducted with a small number
of samples because of the ex vivo nature of the study. In addition,
we did not validate the accuracy of measurement usingpathohistology data as the reference and gold standard of plaque
characterization.
Conclusions
In the present ex vivo study, geometrical and compositional
assessments using 45-MHz rotational VH IVUS showed good
agreement and acceptable reproducibility. Our results may provide
important information when designing future clinical studies.
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